Our societal commitment

In 2024, Financière de Tubize has invested €280k in the support of researchers entrepreneurs aiming at improving access to healthcare for the most disadvantaged.

The family values that drive us naturally lead us to the United Nations’ Sustainable Development Goals, anchoring our commitment to a better and fairer future.

We are convinced that the pursuit of the United Nations’ sustainable development goals will have a long-term positive impact on our financial performance.

Our societal commitment is based on several pillars:

The stability of a long-term reference shareholder base, enabling UCB to make its own societal contribution to the ecosystem of which it is a part (generating jobs, developing R&D skills, attracting talent, supporting local communities, etc.).
The influence of our four representatives on UCB’s Board of Directors as regards defining, monitoring and evaluating UCB’s societal ambitions.
Investing in initiatives with high societal impact that enable disadvantaged populations or those with limited access to healthcare to live longer in good health. In 2024, we refined our vision of the societal impact we want to have. Our company has decided to provide financial support to researchers who wish to commercialise the results of their research focused on improving access to healthcare for as many people as possible. We have chosen Pulse Foundation to help us select and support the researcher-entrepreneurs we support, and have allocated a budget of €280,000 for this long-term project in 2024.
The support of certain organisations dedicated to promoting/defending the interests of the biopharma ecosystem in Belgium and possibly in other geographical areas relevant to UCB.

As a committed reference shareholder of UCB, we attach great importance to the presence of high-performance biopharma ecosystems in Belgium and in geographical areas relevant to UCB.

We focus in particular on the following aspects:

The presence of educational institutions and universities with programs tailored to the specific needs of the biopharma industry in close proximity to operational sites is essential. For research to be successful, it is necessary to find, attract and develop sufficient talent with the right skills.
The removal of barriers that may impede the involvement of diverse talent and the promotion of the international mobility of talent (and their families) to these sites so that they can share their know-how and thus accelerate innovation within the local biopharma ecosystem.
The creation of strong collaborative partnerships that foster innovation.
Interactions with the public authorities in order to encourage them to create an environment conducive to research and development in the biopharma ecosystem, promoting investments in the sector.

The family values that drive us naturally lead us to the United Nations’ Sustainable Development Goals, anchoring our commitment to a better and fairer future.

We are convinced that the pursuit of the United Nations’ sustainable development goals will have a long-term positive impact on our financial performance.

Our societal commitment is based on several pillars:

The stability of a long-term reference shareholder base, enabling UCB to make its own societal contribution to the ecosystem of which it is a part (generating jobs, developing R&D skills, attracting talent, supporting local communities, etc.).
The influence of our four representatives on UCB’s Board of Directors as regards defining, monitoring and evaluating UCB’s societal ambitions.
Investing in initiatives with high societal impact that enable disadvantaged populations or those with limited access to healthcare to live longer in good health. In 2024, we refined our vision of the societal impact we want to have. Our company has decided to provide financial support to researchers who wish to commercialise the results of their research focused on improving access to healthcare for as many people as possible. We have chosen Pulse Foundation to help us select and support the researcher-entrepreneurs we support, and have allocated a budget of €280,000 for this long-term project in 2024.
The support of certain organisations dedicated to promoting/defending the interests of the biopharma ecosystem in Belgium and possibly in other geographical areas relevant to UCB.

As a committed reference shareholder of UCB, we attach great importance to the presence of high-performance biopharma ecosystems in Belgium and in geographical areas relevant to UCB.

We focus in particular on the following aspects:

The presence of educational institutions and universities with programs tailored to the specific needs of the biopharma industry in close proximity to operational sites is essential. For research to be successful, it is necessary to find, attract and develop sufficient talent with the right skills.
The removal of barriers that may impede the involvement of diverse talent and the promotion of the international mobility of talent (and their families) to these sites so that they can share their know-how and thus accelerate innovation within the local biopharma ecosystem.
The creation of strong collaborative partnerships that foster innovation.
Interactions with the public authorities in order to encourage them to create an environment conducive to research and development in the biopharma ecosystem, promoting investments in the sector.